-
-
Blog
From weight loss to liver health: Why GLP-1 innovation is turning toward MASH
4 min
●October 27, 2025
SubjectWell Team -
-
Blog
How to avoid ineligible patient referrals in clinical trials
3 min
●September 3, 2025
SubjectWell Team -
The power of agency, digital, and database integration.
- CRO, Sponsors
- Digital Marketing, Study support
With the FDA’s Diversity Action Plan taking effect in July 2025, clinical trials must move beyond acknowledgment to real action. Addressing past injustices and present biases is essential to building trust, ensuring inclusivity, and improving healthcare for all.
- CRO, Sponsors
- Diversity
New FMLA guidance now protects job security for patients participating in clinical trials, removing a major barrier to accessing innovative treatments.
- CRO, Site Network, Sites, Sponsors
- Study Connect
Understanding FDA’s Guidance on Diversity Action Plans (DAPs) is vital for health equity in clinical trials. As DAPs become mandatory, sponsors must adapt recruitment strategies for inclusivity.
- CRO, Site Network, Sites, Sponsors
- Diversity
Behind every successful patient recruitment strategy is a well-trained medical contact center. From building patient trust to ensuring HIPAA-compliant communication, contact centers are critical for screening, education, and long-term engagement in clinical trials.
- Study Connect
This growing openness offers a valuable opportunity for sponsors and CROs to engage motivated participants if recruitment strategies are aligned with patient motivations and trust.
- CRO, Patient, Site Network, Sites, Sponsors
In rare disease trials, where patients are few and diagnosis is complex, trusted healthcare providers play a critical role in bridging the gap. This blog explores why HCP outreach is a powerful and often overlooked tool for patient recruitment, and how it can drive more qualified referrals and meaningful engagement.
- CRO, Site Network, Sites, Sponsors
- Study Connect
Exploring how compensation practices in clinical trials contribute to inequities and hinder diverse patient participation
- CRO, Site Network, Sites, Sponsors
- Study Connect
The impact of secondary conditions on clinical trial interest.
WHY SUBJECTWELL
It’s time to transform patient recruitment
-
300,000
patients added monthly to our network
47%
registered patients of color
100+
clinically trained patient companions
-
300,000
patients added monthly to our network
47%
registered patients of color
100+
clinically trained patient companions
-
300,000
patients added monthly to our network
47%
registered patients of color
100+
clinically trained patient companions
Their tailored approach helped us meet our recruitment target ahead of schedule. Highly recommend!
Name
Job Description
Accelerate your recruitment today
SubjectWell is here to help you reach, recruit, and retain the patients you need for a successful clinical trial. Schedule a demo to see how SubjectWell+ can support your clinical study’s patient recruitment goals.